Gastric cancer in Iran 1966-2006

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 3, 2009, Pages 407-412

  Mousavi, Seyed Mohsen ^a,b,c,d   Somi, Mohammad Hossein ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Early detection; Epidemiology; Gastric cancer; Incidence; Iran; Mortality

Indexed keywords

EID: 75149176941     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Abdi-Rad A, Ghaderi-Sohi S, Nadimi-Barfroosh H, Emami S (2006).Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran. Diagn Pathol, 1, 5.
2. Asadi Pouya AA, Sadeghi Hasan Abadi A (1997). Epidemiology and demography of benign and malignant tumor in Fars province. J Yasuj University of Medicine, 2, 34-42 (in Persian).
3. Azarm T, Bahmanziari F, Raei H, et al (1997). Epidemiology of cancer in 5 years survey from 1990 to 1995. Pajouhesh in Medicine, 5, 109-12 (in Persian).
4. Babaei M (1993). Gastric cancer. J Zanjan University of Medical Sciences, 7-8, 29-43 (in Persian).
5. Babaei M, Jaafarzadeh H, Samadi F, et al (2009). Cancer incidence and mortality in Ardabil: The first report of an ongoing population-based cancer registry in Iran, 2004-2006. (in press).
6. Babaei M, Mousavi S, Malek M, et al (2005). Cancer incidence in cities covered by Semnan University of Medical Sciences, result of population based cancer registry. J Semnan University of Medical Sciences, 6, 237-44 (in Persian).
7. Babaei M, Mousavi S, Toussy J (2006). Cancer occurrence in old age: Results of a population-based cancer registry in Semnan, Iran. Asian Pac J Cancer Prev, 7, 191-4.
8. Barekat AA, Saidi F, Dutz W (1971). Cancer survey in south Iran with special reference to gastrointestinal neoplasms. Int J Cancer, 7, 353-63.
9. Blot W, Devesa SS, Kneller RW, Fraumeni JF Jr (1991). Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 265, 1287-9.
10. Botterweck AAM, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA (2000). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29, 645-54.
11. Davood Abadi A.H, Sharifi H, Erfan N, Dianati M, AbdolRahim Kashi E (2003). An epidemiologic and clinical survey on gastric cancer patients refered to Shahid Beheshti Hospital of Kashan (1994-2001). J Iran University of Medical Sciences, 10, 211-22 (Persian).
12. Derakhshan MH, Yazdanbod A, Sadjadi AR, et al (2004). High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut, 53, 1262-6.
13. Dutz W, Kohout E, Vessal K (1979). Epidemiologic studies of gastric carcinoma: comparison between Iranians and two racial groups in the USA. Isr J Med Sci, 15, 410-3.
14. Esmaeilnasab N, Moradi G, Zarei M, Ghaderi A, Gheitasi B (2006). Epidemiology and incidence rate of cancers in population over 15 years old in Kordestan. J Kordestan University of Medical Sciences, 11, 18-25 (in Persian).
15. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Version 2.0.IARC Cancer Base no 5. Lyon: IARC Press, 2004, (http://www-depdb.iarc.fr/globocan2002.htm ).
16. Ganji A, Safavi M, Noraei M, et al (2006). Digestive and liver diseases statistics in several referral centers in Tehran, 2000-2004. Govaresh, 11, 33-7 (in Persian).
17. Ghavamzadeh A, Ahmadi F, Jahani M (1993). Combination of 5FU and epirubicin in the treatment of advanced gastric cancer. Acta Medica Iranica, 31, 19-22.
18. Habibi A (1970). Survey on the most common cancers in Iran. Bull Cancer, 57, 133-50.
19. Haghighi P, Nasr K (1971). Gastrointestinal cancer in Iran. J Chronic Dis, 24, 625-33.
20. Hajiani E , Hossein SS, Rahim M, et al (2006). Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol, 12, 4832-5.
21. Hemminki K, Li X (2003). Finnish and Swedish genotypes and risk of cancer in Sweden. Eur J Hum Genet, 11, 207-9.
22. Hemminki K, Li X (2002). Cancer risks in Nordic immigrants and their offspring in Sweden. Eur J Cancer, 38, 2428-34.
23. Hoda S, Aliee A, Shakiba M, Odi M, Ghasemi Poor M, Poor Rasooli Z. A Study of Frequency of Cancerous Organs in Guilan Province (1999-2000). Journal of GuilanUniversity of Medical Sciences, 2003;12(46):84-96(Persian).
24. Hormozdiari H, Day NE, Aramesh B, Mahboubi E. Dietary factors and esophageal cancer in the Caspian Littoral of Iran. Cancer Res. 1975 Nov;35(11 Pt. 2):3493-8.
25. Hosseini SN, Mousavinasab N, Moghimi MH, Fallah R. GC diagnosis and treatment delays from symptom onset to surgery. Journal of Tabriz University of Medical Sciences. 2007; 29(2):39-42 (Persian).
26. Hossein Somi M, Mirinezhad K, Farhang S, et al (2006). Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev, 7, 309-12.
27. Inoue M, Tsugane S (2005). Epidemiology of gastric cancer in Japan. Postgrad Med J, 81, 419-24.
28. Irvani SH, Sadeghi SH (2006). Evaluation of epidemiological characteristics of patients with GC in Shohada-e-Tajrish Medical Center between 1999 to 2005. JAUMS, 4, 825-8 (in Persian).
29. Islami F, Kamangar F, Aghcheli K, et al. (2004). Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer, 90, 1402-6.
30. Jemal A, Siegel R, Ward E, et al. (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96.
31. Kelley JR, Duggan JM (2003). Gastric cancer epidemiology and risk factors. J Clin Epidemiol, 56, 1-9.
32. Khorgami Zh, Hosseini Araghi N (2007). Assessment of factors causing delay to surgical treatment of patients with gastrointestinal malignancies in Surgery Wards of Cancer Institute and Dr. Shariati Hospital in 2004-6. Govaresh, 12, 75-81 (in Persian).
33. Mahboubi E, Kemet J, Cook PJ, et al (1973). Oesophageal cancer studies in the Caspian littoral of Iran: the Caspian Cancer Registry. Br J Cancer, 28, 197-214.
34. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al. (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42.
35. Marjani A, Kabir MJ, Semnani S (2007). Stomach cancer incidence among males in Golestan province, Iran. Indian J Gastroenterol, 26, 299.
36. Maruyama M, Takeshita K, Endo M, et al (1998). Clinicopathological study of gastric carcinoma in high-and lowmortality countries: comparison between Japan and the United States. Gastric Cancer, 1, 64-70.
37. Mehrabi Y, Yavari P, Abadi A ( 2004). A study of cancer patterns among inpatients of public hospitals in Iran. Asian Pac J Cancer Prev, 5, 387-92.
38. Middle East Cancer Consortium (MECC) monograph (2005), Executive summary; 3:35-39 http://oia.cancer.gov/pdf/mecc_monograph.pdf.
39. Moghimi Dehkordi B, Rejaeifard A, Tabatabaei SH, Zighami B, Safaei A (2007). Survival analysis modeling by Cox's model in gastric cancer patients. Iranian Epidemiology J, 3, 19-24 (in Persian).
40. Mohagheghi M, Mosavi-Jarrahi A (2006). Cancer Incidence in the Population of Tehran Metropolis, 1998-2001. The Cancer Institute Cancer Research Center, Tehran, Iran (in Persian).
41. Mohebbi M, Nourijelyani K, Mahmoudi M, et al. (2008). Time of occurrence and age distribution of digestive tract cancers in Northern Iran. Iranian J Publ Health, 37, 8-19.
42. Molanaei N, Yazdanpanah K, Reshadmanesh N, Rahimi E (2000). Epidemiology of gastric and esophageal cancer in Kordestan province in 1999. J Kordestan University of Medical Sciences, 16, 6-9 (in Persian).
43. Mousavi SM, Alamolhoda AA, Gouya MM, Lickiss NJ (2008). Implementation of comprehensive national cancer control program in Iran: an experience in a developing country. Ann Oncol, 19, 398-400.
44. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
45. Mousavi SM, Harirchi I, Ebrahimi M, et al (2009). Screening of breast cancer in Iran: A challenge for health policy makers. The Breast Journal, 14, 605-6.
46. Mousavi SM, Ramazani R, Davanloo M, Hajsadeghi N, Jalal R, Ramezan Shirazi M. National Cancer Registry Report 2005-2006. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office: Feb.2008.
47. Mousavi SM, Zheng T, Dastgiri S, Miller AB (2009). Age distribution of breast cancer in the Middle East, implications for screening. The Breast Journal, 14, (in press).
48. Mousavi SM. Comprehensive National Cancer Control Program in Iran. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office: May.2007.
49. Naghavi M, Jafari N (2007). Mortality views in 29 Provinces of Iran in 2004-Ministry of Health, Deputy for Health Directory, Research and Development Office, Tehran, Iran, (in Persian).
50. Naghavi M ( 2006). Mortality views in 29 Provinces of Iran in 2004-Ministry of Health, Deputy for Health Directory, Research and Development Office, 111-191 (in Persian).
51. National Cancer Registry Data 2006-2007. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office: July. 2008 (unpublished data).
52. Noori Nayer B, Akhondi S, Asadzadeh H, et al (2005). A survey on gastric cancer indexes in Tehran and seven provinces in Iran from 1999 to 2001. J Azad University of Medical Sciences, 15, 15-8 (in Persian).
53. Powell J, McConkey CC (1990). Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer, 62, 440-3.
54. Ratzer ER, Haghighi P, Brasfield RD (1966). Malignant gastric ulcer. Am J Surg, 111, 708-11.
55. Ries LAG, Melbert D, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2005/results_merged/sect_24_stomach.pdf
56. Sadighi S, Mohagheghi MA, Montazeri A, Sadighi Z (2006). Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC Cancer, 6, 274.
57. Sadighi S, Raafat J, Mohagheghi M, Meemary F (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6.
58. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.
59. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
60. Sadjadi A, Zahedi MJ, Darvish Moghadam S, et al (2007). The First population-based cancer survey in Kerman Province of Iran. Iranian J Publ Health, 36, 26-34.
61. Semnani S, Roshandel G, Keshtkar A, et al (2008). Golestan population-based cancer registry. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences. 84-95 (in Persian).
62. Sharifi H, Dianati M, Masood SA (1999). A study on the frequency, anatomical site, and clinical signs, and laboratory findings of stomach cancer patients referring to Kashan Beheshti Hospital from 1993 to 1999. J Yasuj University of Medical Sciences, 4, 43-8 (in Persian).
63. Somi M H, Mirinezhad K, Farhang S, et al (2006). Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev, 7, 309-12.
64. Somi MH, Farhang S, Mirnejad SK, et al (2008). Cancer in East Azerbaijan, Iran: result of a population based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
65. Tsugane S, de Souza JM, Costa ML Jr, et al (1990). Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control, 1, 189-93.
66. Yavari P, Hislop TG, Bajdik C, et al (2006). Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev, 7, 86-90.
67. Yazdanbod A, Nasseri-Moghaddam S, Malekzadeh R (2004). upper gastrointestinal cancer in Ardebil, North-West of Iran: A Review. Arch Iranian Med, 7, 173-7.
68. Yazdanbod A, Arshi S, Derakhshan MH, Sadjadi AR, Malekzadeh R (2001). Gastric cardia cancer, the most common upper gastrointestinal cancer in Ardebil, Iran: An endoscopy clinic experience. Arch Irn Med, 4, 76-9.
69. Yazdanbod A, Malekzadeh R, Derakhshan MH, Sadjadi AR (2000). Gastric cardia cancer, the most common upper gastrointestinal cancer in Ardebil, results by an endoscopic clinic. Govaresh, 417, 67-70 (in Persian).
70. Yazdanbod A, Samadi F, Malekzadeh R, et al (2005). Four years survival rate of gastrointestinal cancers in Ardebil province. J Ardebil University of Medical Sciences, 5, 180-4 (in Persian).
71. Yazdizadeh B, Jarrahi AM, Mortazavi H, et al (2005). Time trends in the occurrence of major GI cancers in Iran. Asian Pac J Cancer Prev, 6, 130-4.
72. Zahedi MJ, Darvish Moghaddam S, Hiatbakhsh Abbasi M, Zeinalinejad H (2005). The prevalence of gastrointestinal cancers in Kerman province in 1996-2000. J Kerman University of Medical Sciences, 12, 153-8 (in Persian).
73. Zeraati H, Mahmoudi M, Kazemnejad A, Mohammed K (2005). Postoperative life expectancy in gastric cancer patients and its associated factors. Saudi Med J, 26, 1203-7.